<code id='C208E43FC8'></code><style id='C208E43FC8'></style>
    • <acronym id='C208E43FC8'></acronym>
      <center id='C208E43FC8'><center id='C208E43FC8'><tfoot id='C208E43FC8'></tfoot></center><abbr id='C208E43FC8'><dir id='C208E43FC8'><tfoot id='C208E43FC8'></tfoot><noframes id='C208E43FC8'>

    • <optgroup id='C208E43FC8'><strike id='C208E43FC8'><sup id='C208E43FC8'></sup></strike><code id='C208E43FC8'></code></optgroup>
        1. <b id='C208E43FC8'><label id='C208E43FC8'><select id='C208E43FC8'><dt id='C208E43FC8'><span id='C208E43FC8'></span></dt></select></label></b><u id='C208E43FC8'></u>
          <i id='C208E43FC8'><strike id='C208E43FC8'><tt id='C208E43FC8'><pre id='C208E43FC8'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:8
          A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat
          PATRICK T. FALLON/AFP via Getty Images

          You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

          Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

          advertisement

          He had a point.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          In science, is the line between industry and academia shifting?
          In science, is the line between industry and academia shifting?

          AkiraSuemori/APAfewyearsago,VijayPande,thenaprofessoratStanfordwhowasusingcomputersciencetounderstan

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Why more medical students aren't specializing in primary care

          AdobeTheU.S.isrunninglowonprimarycarephysicians,withanestimatedshortageofbetween17,800and48,000predi